Effect of clinical and probiotic Lactobacillus rhamnosus strains on intestinal permeability and bacterial translocation in healthy and colitic rats

Food Research International

Volumn 42, Issue 5-6, 2009, Pages 636-640

  Frias, Rafael ^a,b   Ouwehand, Arthur ^c   Spillmann, Thomas ^b   Vankerckhoven, Vanessa ^d   Hewicker Trautwein, Marion ^e   Salminen, Seppo ^c   Gueimonde, Miguel ^c,f  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^f DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

Author keywords

Gut permeability; Lactobacillus; Lactobacillus rhamnosus; Probiotics; Safety; Translocation

Indexed keywords

GUT PERMEABILITY; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; SAFETY; TRANSLOCATION;

ANIMALS; BACTERIOLOGY; CAPILLARITY; STRAIN;

BACTERIA;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; RATTUS;

EID: 67349128626     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2009.02.004     Document Type: Article

References (21)

1. Berg R.D. Bacterial translocation from the gastrointestinal tract. Advances in Experimental Medicine and Biology 473 (1999) 11-30
2. Besselink M.G.H., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet 371 9613 (2008) 651-659
3. Cooper H.S., Murthy S.N., Shah R.S., and Sedergran D.J. Clinopathologic study of dextran sulphate sodium experimental colitis. Laboratory Investigation 69 (1993) 238-249
4. Daniel C., Poiret S., Goudercourt D., Dennin V., Leyer G., and Pot B. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Applied and Environmental Microbiology 72 9 (2006) 5799-5805
5. Farthing D., Sica D.A., Fakhry I., Laurus T., Ghosh S., Farthing C., et al. Simple HPLC-UV method for determination of iohexol, iothalamate, p-aminohippuric acid and n-acetyl-p-aminohippuric acid in human plasma and urine with ERPF, GFR and ERPF/GFR ratio determination using colorimetric analysis. Journal of Chromatography B - Analytical Technologies in the Biomedical and Life Sciences 826 1-2 (2005) 267-272
6. Gaudio E., Taddei G., Vetuschi A., Sferra R., Frieri G., Ricciardi G., et al. Dextran sulfate sodium (DSS) colitis in rats: Clinical, structural, and ultrastructural aspects. Digestive Diseases and Science 44 (1999) 1458-1475
7. Geier M.S., Butler R.N., Giffard P.M., and Howarth G.S. Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulphate sodium (DSS) in rats. International Journal of Food Microbiology 114 3 (2007) 267-274
8. Grauer G.F., Thomas C.B., and Eicker S.W. Estimation of quantitative proteinuria in the dog, using the urine protein-to-creatinine ratio from a random, voided sample. American Journal of Veterinary Research 46 10 (1985) 2116-2119
9. Gueimonde M., Frias R., and Ouwehand A. Assuring the continuous safety of lactic acid bacteria used as probiotics. Biologia 61 (2006) 755-760
10. Herias M.V., Koninkx J.F.J.G., Vos J.G., Huis in't Veld J.H.J., and Van Dijk J.E. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice. International Journal of Food Microbiology 103 2 (2005) 143-155
11. Klenner S., Bergmann C., Strube K., Ternes W., and Spillmann T. SPE for endo- and exo-iohexol analysis with HPLC in canine serum and rat urine. Chromatographia 65 11-12 (2007) 733-736
12. Lee D.J., Drongowski R.A., Coran A.G., and Harmon C.M. Evaluation of probiotic treatment in a neonatal animal model. Pediatric Surgery International 16 4 (2000) 237-242
13. MacFie J., O'Boyle C., Mitchell C.J., Buckley P.M., Johnstone D., and Sudworth P. Gut origin of sepsis: A prospective study investigating associations between bacterial translocation gastric microflora and septic morbidity. Gut 45 2 (1999) 223-228
14. Ouwehand A.C., Saxelin M., and Salminen S. Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clinical Infectious Diseases 39 12 (2004) 1858-1860
15. Pavan S., Desreumaux P., and Mercenier A. Use of mouse models to evaluate the persistence safety and immune modulation capacities of lactic acid bacteria. Clinical and Diagnostic Laboratory Immunology 10 4 (2003) 696-701
16. Pena J.A., Rogers A.B., Ge Z., Ng V., Li S.Y., Fox J.G., et al. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infection and Immunity 73 2 (2005) 912-920
17. Salminen S.J., Gueimonde M., and Isolauri E. Probiotics that modify disease risk. Journal of Nutrition 135 5 (2005) 1294-1298
18. Salminen M.K., Tynkkynen S., Rautelin H., Saxelin M., Vaara M., Ruutu P., et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clinical Infectious Diseases 35 10 (2002) 1155-1160
19. Vankerckhoven V., Huys G., Vancanneyt M., Vael C., Klare I., Romond M.-B., et al. Biosafety assessment of probiotics used for human consumption: Recommendations from the EU-PROSAFE project. Trends in Food Science and Technology 19 2 (2008) 102-114
20. Vankerckhoven V., Moreillon P., Piu S., Giddey M., Huys G., Vancanneyt M., et al. Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis. Journal of Medical Microbiology 56 8 (2007) 1017-1024
21. Vesterlund S., Vankerckhoven V., Saxelin M., Goosens H., Salminen S., and Ouwehand A.C. Safety assessment of Lactobacillus strains: Presence of putative risk factors in faecal, blood and probiotic isolates. International Journal of Food Microbiology 116 3 (2007) 325-331